Identification of CD44 as a Surface Biomarker for Drug Resistance by Surface Proteome Signature Technology

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Molecular Cancer Research

• Publication date

  2011-02-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1541-7786.MCR-09-0237PMID 21357442PMCID PMC3096711
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hyaluronan-mediated CD44 Interaction with p300 and SIRT1 Regulates β-Catenin Signaling and NFκB-specific Transcription Activity Leading to MDR1 and Bcl-xL Gene Expression and Chemoresistance in Breast Tumor Cells*

  2009influential reference
• REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer

  2009cited by this paper
• Critical review of microarray-based prognostic tests and trials in breast cancer

  2008cited by this paper
• Osteopontin: regulation in tumor metastasis

  2008cited by this paper
• Design of recombinant antibody microarrays for cell surface membrane proteomics.

  2008cited by this paper
• A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells.

  2007cited by this paper
• Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms

  2007cited by this paper
• Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification

  2007cited by this paper
• Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells

  2007cited by this paper
• Biomarkers and multiple drug resistance in breast cancer.

  2006cited by this paper
• cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance

  2006cited by this paper
• Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective.

  2006cited by this paper
• A novel antiapoptotic mechanism based on interference of Fas signaling by CD44 variant isoforms

  2006cited by this paper
• Functional proteomic screen identifies a modulating role for CD44 in death receptor-mediated apoptosis.

  2005influential reference
• Hyaluronan synthase expression in pleural malignant mesotheliomas

  2005cited by this paper
• Genomics in breast cancer—therapeutic implications

  2005cited by this paper
• Regulation of MDR1 Expression and Drug Resistance by a Positive Feedback Loop Involving Hyaluronan, Phosphoinositide 3-Kinase, and ErbB2*♦

  2005cited by this paper
• Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasiveness

  2004cited by this paper
• Proteomic phenotyping: metastatic and invasive breast cancer.

  2004cited by this paper
• CD155/PVR plays a key role in cell motility during tumor cell invasion and migration

  2004cited by this paper
• Hyaluronan: from extracellular glue to pericellular cue

  2004cited by this paper
• CD44 in Cancer Progression: Adhesion, Migration and Growth Regulation

  2003cited by this paper
• Multidrug-resistant MCF-7 cells: an identity crisis?

  2002cited by this paper
• The sequence of the human genome (abstract only)

  2001cited by this paper
• Initial sequencing and analysis of the human genome

  2001cited by this paper
• The sequence of the human genome. Venter JC,∗ Adams MD, Myers EW, et al. Science 2001;291:1304–1351.

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000influential reference
• Proteomics to study genes and genomes

  2000cited by this paper
• Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival.

  2000cited by this paper
• Bcl‐xL regulates apoptosis by heterodimerization‐dependent and ‐independent mechanisms

  1999cited by this paper
• Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate

  1999cited by this paper
• Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen.

  1998cited by this paper
• Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer.

  1998cited by this paper
• Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases.

  1997cited by this paper
• The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.

  1997cited by this paper
• Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells.

  1987cited by this paper
• Sequence the Human Genome

  1986cited by this paper
• Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells.

  1986cited by this paper
• Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats.

  1986cited by this paper
• Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential.

  1983cited by this paper

• Immune Cell-Specific and Isoform-Selective Regulation of CD44 in Pancreatic Ductal Adenocarcinoma Links Lymph Node Variant Loss and Exosomal CD44 to Clinical Outcome in Pancreatic Ductal Adenocarcinoma

  2026cites this paper
• Recent developments in sustained-release and targeted drug delivery applications of solid lipid nanoparticles

  2025cites this paper
• CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance

  2023cites this paper
• Cancer Stem Cells Persist Despite Cellular Damage, Emergence of the Refractory Cell Population

  2023cites this paper
• CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer

  2022cites this paper
• Extracellular matrix and its therapeutic potential for cancer treatment

  2021cites this paper
• Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA.

  2021cites this paper
• CD44 enhances adriamycin resistance in chronic myelogenous leukaemia cells K562

  2021cites this paper
• Smart Mesoporous Silica Nanoparticles for Protein Delivery

  2019cites this paper
• Epithelial-mesenchymal transition as a mechanism of resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma

  2019cites this paper
• The Role of Proteomics in Cancer Research

  2019cites this paper
• Hyaluronic acid-coated solid lipid nanoparticles to overcome drug-resistance in tumor cells

  2019cites this paper
• The level of intracellular tacrolimus in T cell is affected by CD44+ ABCB1+ activities triggered by inflammation

  2019cites this paper
• Protein microarray technology: Assisting personalized medicine in oncology (Review)

  2019influential citation
• Bladder Cancer Chemotherapy Resistant Cell Harbors Stem-Like Characteristics Construction and Characterization of T24 Resistance Strain of Bladder Cancer

  2019cites this paper
• Functional extracellular vesicles engineered with lipid-grafted hyaluronic acid effectively reverse cancer drug resistance.

  2019cites this paper
• Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma

  2019cites this paper
• Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL‐6/Stat3 signaling

  2018cites this paper
• Targeting CD44 by CRISPR-Cas9 in Multi-Drug Resistant Osteosarcoma Cells

  2018cites this paper
• Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer

  2017cites this paper
• Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer

  2016cites this paper
• The Role of CD44 and ERM Proteins in Expression and Functionality of P-glycoprotein in Breast Cancer Cells

  2016cites this paper
• Hybrid Nanomaterials Based on Iron Oxide Nanoparticles and Mesoporous Silica Nanoparticles: Overcoming Challenges in Current Cancer Treatments

  2016cites this paper
• CD44 promotes chemoresistance in T-ALL by increased drug efflux.

  2016influential citation
• miR-199a-3p and contributes to aggressive progression in

  2015cites this paper
• Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer

  2015cites this paper
• CD44-engineered mesoporous silica nanoparticles for overcoming multidrug resistance in breast cancer

  2015cites this paper
• CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma

  2015cites this paper
• Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells

  2015cites this paper
• The exploration of CD44 as a mediator of a drug resistant phenotype in ER+ breast cancer

  2015cites this paper
• Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells.

  2015cites this paper
• Hyaluronic Acid Modified Tantalum Oxide Nanoparticles Conjugating Doxorubicin for Targeted Cancer Theranostics.

  2015cites this paper
• Up-regulation of CD 44 in the development of metastasis , recurrence and drug resistance of ovarian cancer

  2015cites this paper
• Identification of chemoresistance-related cell-surface glycoproteins in leukemia cells and functional validation of candidate glycoproteins.

  2014cites this paper
• Targeted Therapeutic Nanotubes Influence the Viscoelasticity of Cancer Cells to Overcome Drug Resistance

  2014cites this paper
• Gene signatures of drug resistance predict patient survival in colorectal cancer

  2014cites this paper
• Development of drug loaded nanoparticles for tumor targeting. Part 2: Enhancement of tumor penetration through receptor mediated transcytosis in 3D tumor models.

  2013cites this paper
• Exploring the role of CD44 in tamoxifen resistant breast cancer

  2013cites this paper
• A framework for personalized medicine: prediction of drug sensitivity in cancer by proteomic profiling

  2012cites this paper
• Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan

  2012cites this paper
• Proteomic Analyses of Sirt1-Mediated Cisplatin Resistance in OSCC Cell Line

  2011cites this paper
• Sr Proteins in Microrna/mrna Biogenesis

  year unknowncites this paper